Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 1,165,528 | 1,129,530 | 1,142,647 | 1,133,416 | 1,171,642 |
| Cost of Goods | 770,626 | 737,449 | 740,405 | 748,656 | 748,650 |
| Gross Profit | 394,902 | 392,081 | 402,242 | 384,760 | 422,992 |
| Operating Expenses | 244,127 | 226,765 | 228,341 | 683,928 | 254,029 |
| Operating Income | 151,401 | 165,765 | 174,306 | -298,512 | 169,613 |
| Interest Expense | 20,969 | 33,342 | 42,586 | 35,279 | 21,682 |
| Other Income | 7,895 | -2,677 | 942 | -291 | 3,626 |
| Pre-tax Income | 138,327 | 129,746 | 132,662 | -334,082 | 151,557 |
| Income Tax | 32,911 | 27,628 | 17,140 | 23 | 40,354 |
| Net Income Continuous | 105,416 | 102,118 | 115,522 | -334,105 | 111,203 |
| Net Income Discontinuous | -1,265 | -4,252 | -5,545 | -8,012 | 1,399 |
| Minority Interests | 1,323 | 571 | 411 | -5,448 | -1,839 |
| Net Income | $102,828 | $97,295 | $109,566 | $-336,669 | $114,441 |
| EPS Basic Total Ops | 2.15 | 2.03 | 2.16 | -5.38 | 1.75 |
| EPS Basic Continuous Ops | 2.18 | 2.12 | 2.26 | -5.25 | 1.73 |
| EPS Basic Discontinuous Ops | -0.03 | -0.09 | -0.11 | -0.13 | 0.02 |
| EPS Diluted Total Ops | 2.12 | 2.01 | 2.14 | -5.38 | 1.74 |
| EPS Diluted Continuous Ops | 2.15 | 2.10 | 2.24 | -5.25 | 1.72 |
| EPS Diluted Discontinuous Ops | -0.03 | -0.09 | -0.11 | -0.13 | 0.02 |
| EBITDA(a) | $257,598 | $264,662 | $279,546 | $119,914 | $273,373 |